CIK 0001880438 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
AN2 Therapeutics, Inc.
Sign in to watch- Ticker
- ANTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 820606654
- Phone
- (650) 331-9090
- Business address
- 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $11,602
- in 1 filing
- Open-market sales, last 90 days
- $117,428
- in 4 filings, $104K under 10b5-1 plans
Net −$105,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 94 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-04 | Eizen Joshua M See Remarks | Sale | −2,819 | $1.14 | $3K | 177,353 |
| 2025-11-04 | Prior Stephen David Chief Strategy Officer | Sale | −765 | $1.14 | $872 | 65,548 |
| 2025-10-10 | Marks Gilbert Lynn Director | Grant or award | +10,367 | 63,749 | ||
| 2025-10-10 | Aziz Kabeer Director | Grant or award | +10,367 | 40,919 | ||
| 2025-10-10 | Martin Patricia A. Director | Grant or award | +3,274 | 13,255 | ||
| 2025-07-10 | Aziz Kabeer Director | Grant or award | +11,875 | 30,552 | ||
| 2025-07-10 | Marks Gilbert Lynn Director | Grant or award | +11,875 | 53,382 | ||
| 2025-07-10 | Martin Patricia A. Director | Grant or award | +3,750 | 9,981 | ||
| 2025-06-02 | Easom Eric Chief Executive Officer | Purchase | +10,000 | $1.07 | $11K | 256,380 |
| 2025-05-30 | Leonard Braden Michael 10% owner | Sale | −425,000 | $1.01 | $429K | 3,224,432 |
| 2025-05-30 | Leonard Braden Michael 10% owner | Sale | −7,000 | $1.03 | $7K | 3,217,432 |
| 2025-05-28 | Leonard Braden Michael 10% owner | Sale | −200,000 | $1.09 | $218K | 3,017,432 |
| 2025-05-28 | Leonard Braden Michael 10% owner | Sale | −2,000,000 | $1.16 | $2.3M | 3,749,432 |
| 2025-05-28 | Leonard Braden Michael 10% owner | Sale | −100,000 | $1.16 | $116K | 3,649,432 |
| 2025-05-28 | FitzPatrick Margaret M Director | Purchase | +8,610 | $1.18 | $10K | 8,610 |
| 2025-05-22 | Readnour Robin Shane Director | Grant or award · Stock Option (Right to Buy) | +19,111 | 19,111 | ||
| 2025-05-22 | Martin Patricia A. Director | Grant or award · Stock Option (Right to Buy) | +19,111 | 19,111 | ||
| 2025-05-22 | FitzPatrick Margaret M Director | Grant or award · Stock Option (Right to Buy) | +19,111 | 19,111 | ||
| 2025-05-22 | Zakrzewski Joseph S Director | Grant or award · Stock Option (Right to Buy) | +19,111 | 19,111 | ||
| 2025-05-22 | Spigelman Melvin K Director | Grant or award · Stock Option (Right to Buy) | +19,111 | 19,111 |
Page 7 of 10 · 191 trades